Methyl N-[(1S)-1-[[(2S)-2-[5-[6-[2-[(2S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-2-pyrrolidinyl]-1H-benzimidazol-6-yl]-2-naphthalenyl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]-2-methylpropyl]carbamate
- Catalog No. :
- ACTADE689
- CAS No. :
- 1242087-93-9
- Molecular Formula :
- C42H50N8O6
- Molecular Weight :
- 762.91
IUPAC Name:methyl ((S)-1-((S)-2-(5-(6-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-benzo[d]imidazol-6-yl)naphthalen-2-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$449.00Login to see priceInquiryInquiry
Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.
0 Reviews:View Reviews
Product Information
| Product Name | Methyl N-[(1S)-1-[[(2S)-2-[5-[6-[2-[(2S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-2-pyrrolidinyl]-1H-benzimidazol-6-yl]-2-naphthalenyl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]-2-methylpropyl]carbamate |
|---|---|
| IUPAC Name | methyl ((S)-1-((S)-2-(5-(6-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-benzo[d]imidazol-6-yl)naphthalen-2-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate |
| MDL No. | MFCD30531532 |
| Molecular Formula | C42H50N8O6 |
| Molecular Weight | 762.91 |
| SMILES | O=C(OC)N[C@H](C(N1[C@H](C2=NC=C(C3=CC=C4C=C(C5=CC=C6N=C([C@H]7N(C([C@@H](NC(OC)=O)C(C)C)=O)CCC7)NC6=C5)C=CC4=C3)N2)CCC1)=O)C(C)C |
| InChI Key | LCHMHYPWGWYXEL-ZYADHFCISA-N |
| Synonym | ravidasvir,PPI-668;Ravidasvir;Sifuvirtide;Ravidasvir1242087-93-9;BI 238630;PPI-668;PPI-668;BI 238630;Carbamic acid, N-[(1S)-1-[[(2S)-2-[5-[6-[2-[(2S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-2-pyrrolidinyl]-1H-benzimidazol-6-yl]-2-naphthalenyl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]-2-methylpropyl]-, methyl ester |
| CAS No. | 1242087-93-9 |
Safety Data
- Pictogram
- Signal Word
- Achtung
- Hazard Statement(s)
- H302-H315-H319-H335
- Precautionary Statement(s)
- P261-P305+P351+P338

